6-84149564-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014895.4(CEP162):c.3769G>A(p.Glu1257Lys) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000509 in 1,590,522 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014895.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152084Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000974 AC: 23AN: 236226Hom.: 0 AF XY: 0.000109 AC XY: 14AN XY: 128078
GnomAD4 exome AF: 0.0000521 AC: 75AN: 1438320Hom.: 1 Cov.: 29 AF XY: 0.0000741 AC XY: 53AN XY: 715476
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74408
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.3769G>A (p.E1257K) alteration is located in exon 24 (coding exon 23) of the CEP162 gene. This alteration results from a G to A substitution at nucleotide position 3769, causing the glutamic acid (E) at amino acid position 1257 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at